Cell Banking Outsourcing Market Report 2026

Cell Banking Outsourcing Market Overview

• Cell Banking Outsourcing market size has reached to $12.86 billion in 2025 • Expected to grow to $24.12 billion in 2030 at a compound annual growth rate (CAGR) of 13.1% • Growth Driver: Driving Growth Of Cell Banking Outsourcing Market Amid Rising Burden Of Chronic Diseases • Market Trend: Innovative Single Cell Potency Characterization Platform Revolutionizes Cell Therapy Research • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cell Banking Outsourcing Market?

Cell banking outsourcing refers to the practice of contracting external organizations to establish, maintain, and manage repositories of cell lines crucial for various applications in biotechnology and pharmaceutical industries, such as drug discovery and biomanufacturing. It ensures that cells are handled, stored, and maintained under standardized conditions, ensuring consistency and reliability. The main types of cell banking outsourcing include master cell banking, working cell banking, and viral cell banking. Master cell banking (MCB) refers to a stock of well-characterized cells that are derived from a single clone and are intended to serve as the starting material for the production of therapeutic products, such as biologics or cell therapies. Various types of cells are included, such as stem cell banking and non-stem cell banking, for several phases, including bank storage, bank characterization and testing, and bank preparation.

What Is The Cell Banking Outsourcing Market Growth Forecast?

The cell banking outsourcing market size is expected to see rapid growth in the next few years. It will grow to $24.12 billion in 2030 at a compound annual growth rate (CAGR) of 13.1%. The growth in the forecast period can be attributed to surge in cell and gene therapy pipelines, rising demand for viral vector manufacturing, increasing regulatory focus on cell line traceability, growth of personalized medicine development, expansion of contract development and manufacturing organizations. Major trends in the forecast period include rising outsourcing of gmp-compliant cell banking services, increasing demand for multi-species cell banking capabilities, standardization of cell line documentation and traceability, expansion of viral and vector cell banking for advanced therapies, growing preference for long-term cell bank storage agreements.

Global Cell Banking Outsourcing Market Segmentation

1) By Type: Master Cell Banking, Working Cell Banking, Viral Cell Banking 2) By Cell Type: Stem Cell Banking, Non-Stem Cell Banking 3) By Phase: Bank Storage, Bank Characterization And Testing, Bank Preparation Subsegments: 1) By Master Cell Banking: Human Master Cell Bank, Animal Master Cell Bank 2) By Working Cell Banking: Human Working Cell Bank, Animal Working Cell Bank 3) By Viral Cell Banking: Virus Bank For Vaccine Production, Viral Vector Bank For Gene Therapy, Adenovirus Bank

What Is The Driver Of The Cell Banking Outsourcing Market?

The rise in the burden of chronic diseases is expected to propel the growth of the cell banking outsourcing market going forward. Chronic diseases are long-lasting medical conditions that develop gradually and persist over extended periods, often requiring ongoing management. The increasing burden of chronic diseases is driven by lifestyle changes, aging populations, and genetic predispositions. The cell banking outsourcing market supports chronic disease research by providing specialized infrastructure, advanced technologies, and expert capabilities that enable efficient storage, preservation, and processing of cellular materials used in therapeutic development. For instance, in April 2025, according to the NHS Confederation, a UK-based national association, in 2035, it is estimated that 17% of the UK population could be living with four or more chronic conditions. Therefore, the rise in the burden of chronic diseases is driving the growth of the cell banking outsourcing industry.

Key Players In The Global Cell Banking Outsourcing Market

Major companies operating in the cell banking outsourcing market are Lonza Group Ltd., WuXi AppTec, Charles River Laboratories, Labcorp Drug Development, Covance Inc., SGS Life Sciences, Sartorius AG, BioReliance, Cleancells, Clean Biologics, Texcell, Goodwin Biotechnology Inc., Perfectus Biomed Limited, BioStorage Technologies Inc., Toxikon Corp., PX’Therapeutics SA, Sigma-Aldrich Co. Ltd., Transcell Biolife Pvt Ltd, Eurofins Scientific SE, ViruSure GmbH

Global Cell Banking Outsourcing Market Trends and Insights

Major companies operating in the cell banking outsourcing market are focusing on developing technologically advanced solutions, such as single-cell potency characterization platforms, to deliver more precise potency assessments and support the development of high-quality cell therapies. A single-cell potency characterization platform refers to an advanced analytical system designed to evaluate the functional capabilities and therapeutic potential of individual cells within heterogeneous cell populations, enabling deeper insight into cell behavior, potency, and mechanism of action for research and clinical development. For instance, in January 2024, Cellply Srl, an Italy-based biotechnology company, launched VivaCyte, an end-to-end single-cell potency characterization platform that integrates potency analysis with immunophenotyping, featuring fully automated operation, single-cell resolution, and rapid multi-parameter functional assessment to reduce development time, cost, and risk while enabling comprehensive evaluation of multiple cell therapy candidates across diverse process options.

What Are Latest Mergers And Acquisitions In The Cell Banking Outsourcing Market?

In April 2025, Artis BioSolutions LLC, a US-based healthcare technology company, acquired Landmark Bio for an undisclosed amount. With this acquisition, Artis aims to scale Landmark’s capabilities in translational research and GMP manufacturing to accelerate the development and commercialization of advanced cell and gene therapies. Landmark Bio, PBLLC, is a US-based life sciences company that provides cell banking outsourcing services.

Regional Insights

North America was the largest region in the cell banking outsourcing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cell Banking Outsourcing Market?

The cell banking outsourcing market includes revenues earned by entities by providing services, such as cell line establishment, cryopreservation, cell line characterization, facilitating the distribution of cell lines, and quality control. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cell Banking Outsourcing Market Report 2026?

The cell banking outsourcing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cell banking outsourcing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.